The impact of the SARS-CoV-2 pandemic on screening tests rates in breast and cervical cancer
| dc.contributor.author | Zuzak, Tomasz Zbigniew | |
| dc.contributor.author | Bogaczyk, Anna | |
| dc.contributor.author | Januszek, Natalia | |
| dc.contributor.author | Januszek, Sławomir | |
| dc.contributor.author | Kluz, Tomasz | |
| dc.date.accessioned | 2024-03-12T10:23:40Z | |
| dc.date.available | 2024-03-12T10:23:40Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | The global SARS-CoV-2 pandemic had a significant impact on the availability of screening for breast and cervical cancer. In Poland, two pandemic waves were observed in 2020, characterized by an increase in the number of confirmed cases and deaths caused by the SARS-CoV-2 infection. This situation has reduced the number of patients registering for mammography and cytological tests. The aim of this study is to describe the problem using the available numerical data obtained from the database of the regional branch of the National Health Fund regarding the significant decrease in the number of screening tests for breast and cervical cancer in the Podkarpackie Voivodeship during the SARS-CoV-2 pandemic. | |
| dc.identifier.citation | Medicine and Public Health 2023, nr 1 | |
| dc.identifier.doi | 10.48269/MandPH-AFMKU-23-1-001 | |
| dc.identifier.issn | 2956-9443 | |
| dc.identifier.uri | http://hdl.handle.net/11315/31254 | |
| dc.language.iso | en | |
| dc.publisher | Oficyna Wydawnicza AFM | |
| dc.rights | Uznanie autorstwa-Użycie niekomercyjne-Bez utworów zależnych 3.0 Polska | |
| dc.subject | SARS-CoV-2 pandemic | |
| dc.subject | breast cancer profilaxy | |
| dc.subject | cervical cancer profilaxy | |
| dc.subject | public health | |
| dc.subject.other | Medycyna | |
| dc.subject.other | Zdrowie | |
| dc.title | The impact of the SARS-CoV-2 pandemic on screening tests rates in breast and cervical cancer | |
| dc.type | Artykuł |